CERT (Certara) Moat Score: 7/10 (As of Jun. 24, 2026)


CERT Certara Inc CERT
59 GF Score
Price $5.45
GF Value $13.40
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Certara Moat Score?

Certara CERT +0.83% 59 Moat Score is 7 as of Jun. 24, 2026. GuruFocus rates CERT with a GF Score™ of 59/100 and a GF Value™ of $13.40 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Certara ranks better than 99.56% on this metric.

Certara has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Certara has Wide Moat: CERT possesses a robust wide moat due to its leading position in biosimulation software, significant customer switching costs, and strong intellectual property. Its durable cost advantages and innovation capabilities further solidify its competitive edge.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Certara might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Certara  (NAS:CERT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Certara Moat Score Related Terms

CERT vs TALK, GDRX, OMDA: Moat Score Comparison

For the Health Information Services subindustry, Certara's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Certara Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Certara's Moat Score distribution charts can be found below:

* The bar in red indicates where Certara's Moat Score falls into.


CERT
59GF Score
Certara Inc CERT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Certara (CERT) has a Moat Score of 7 as of Jun. 24, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Certara ranks #3 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 0.40000000000001%.
Is Certara's Moat Score too high?
Certara's current Moat Score is 7. Based on the distribution chart, Certara ranks #3 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Certara has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Certara's Moat Score compare to TALK and GDRX?
According to the Healthcare Providers & Services industry distribution chart, Certara ranks #3 out of 681 companies for Moat Score. This places Certara in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Certara's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Based on GuruFocus' analysis, Certara (CERT) is currently considered Possible Value Trap. The stock's GF Value™ is $13.40, compared to a current price of $5.45 — trading 59.4% below its estimated fair value. The current Moat Score is 7. Certara's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Certara (CERT), the current Moat Score is 7 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Certara (CERT) Overvalued in 2026?

Based on GuruFocus' analysis, Certara stock appears to be undervalued. The current stock price of $5.45 is trading 59.4% below its estimated GF Value™ of $13.40. GuruFocus considers Certara to be Possible Value Trap.

Key valuation signals for CERT:

  • Moat Score: 7
  • GF Value™: $13.40 vs. price of $5.45 (59.4% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Certara Business Description

Address 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
59GF Score

Get the complete analysis for CERT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price
$13.40
GF Value